Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer
This study has been completed.
Sponsor:
Seattle Genetics, Inc.
Information provided by:
Seattle Genetics, Inc.
ClinicalTrials.gov Identifier:
NCT00031187
First received: February 27, 2002
Last updated: October 21, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2003 |
| Estimated Primary Completion Date: | No date given |